One million procedures

One million procedures
Colin Kerr
Colin Kerr
Published: Wednesday, November 1, 2017
James V Mazzo
ZEISS has reported that doctors performing laser vision correction surgery using its SMILE refractive technology have now surpassed one million procedures worldwide. “We are thrilled that SMILE, the first major advancement in laser vision correction since the 1990s, has reached this important milestone and that ZEISS has played an integral role in ushering in a new era in refractive surgery with this proven technology,” said James V Mazzo, Global President Ophthalmic Devices at Carl Zeiss Meditec. “We are honoured to see SMILE so widely accepted by doctors and their patients, and that SMILE has helped doctors restore and improve the vision for so many people around the world.” www.zeiss.com/med
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...